These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6165239)

  • 1. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
    Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
    Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
    Gralnick HR; Givelber HM; Shainoff JR; Finlayson JS
    J Clin Invest; 1971 Sep; 50(9):1819-30. PubMed ID: 5564389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease.
    Ragni MV; Lewis JH; Spero JA; Hasiba U
    Alcohol Clin Exp Res; 1982; 6(2):267-74. PubMed ID: 7048981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
    Carrell N; McDonagh J
    Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
    Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
    Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study.
    Vila V; Regañon E; Fernandez-Pavon A; Aznar J
    Scand J Haematol; 1984 Nov; 33(5):460-5. PubMed ID: 6515329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED; Shainoff JR; Graham RC; Ratnoff OD
    J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
    Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
    Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR; Prchal JT; Mosesson MW
    Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.